Abstract The Food and Drug Administration (FDA) has approved vaccines designed by GSK. copyright and Moderna to protect high-risk populations against respiratory syncytial virus (RSV). These vaccines employ the pre-fusion F (pre-F) protein as the immunogen. In this study. https://www.jmannino.com/hot-offer-Card-50-Number-Pink-Khaki-Stripe-special-buy/